Fingerprint
Dive into the research topics of 'Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: A phase II north central cancer treatment group clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically